REVIEW FOR THE 2015 SATO AWARD : Heart Development, Diseases, and Regeneration : New Approaches From Innervation, Fibroblasts, and Reprogramming

  • Ieda Masaki
    Department of Cardiology, Keio University School of Medicine AMED-PRIME

書誌事項

タイトル別名
  • Heart Development, Diseases, and Regeneration – New Approaches From Innervation, Fibroblasts, and Reprogramming –

この論文をさがす

抄録

<p>It is well known that cardiac function is tightly controlled by neural activity; however, the molecular mechanism of cardiac innervation during development and the relationship with heart disease remain undetermined. My work has revealed the molecular networks that govern cardiac innervation and its critical roles in heart diseases such as silent myocardial ischemia and arrhythmias. Cardiomyocytes proliferate during embryonic development, but lose their proliferative capacity after birth. Cardiac fibroblasts are a major source of cells during fibrosis and induce cardiac hypertrophy after myocardial injury in the adult heart. Despite the importance of fibroblasts in the adult heart, the role of fibroblasts in embryonic heart development was previously not determined. I demonstrated that cardiac fibroblasts play important roles in myocardial growth and cardiomyocyte proliferation during embryonic development, and I identified key paracrine factors and signaling pathways. In contrast to embryonic cardiomyocytes, adult cardiomyocytes have little regenerative capacity, leading to heart failure and high mortality rates after myocardial infarction. Leveraging the knowledge of developmental biology, I identified cardiac reprogramming factors that can directly convert resident cardiac fibroblasts into cardiomyocytes for heart regeneration. These findings greatly improved our understanding of heart development and diseases, and provide a new strategy for heart regenerative therapy. (Circ J 2016; 80: 2081–2088)</p>

収録刊行物

  • Circulation Journal

    Circulation Journal 80 (10), 2081-2088, 2016

    一般社団法人 日本循環器学会

被引用文献 (1)*注記

もっと見る

参考文献 (39)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ